# A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease

> **NCT01442363** · PHASE2 · TERMINATED · sponsor: **Braintree Laboratories** · enrollment: 4 (actual)

## Conditions studied

- Perianal Crohn's Disease

## Interventions

- **DRUG:** BLI-1300 low dose
- **DRUG:** BLI-1300 high dose
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01442363
- **Lead sponsor:** Braintree Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-11
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Lack of recruitment, discontinuation of program
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01442363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01442363, "A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01442363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*